Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007

Medicare Advantage - HR 6331, Medicare Improvements for Patients and Providers Act of 2008; Proposed legislation re this issue. Medigap insurance market issues - Proposed legislation re these issues. Medicare/Medicaid issues - S 706, To amend title XVIII of the Social Security Act to repeal the MA Regional Plan Stabilization Fund; S 130, Medicare Cost Contract Extension and Refinement Act of 2007; HR 1990, Medicare Cost Contract Extension and Refinement Act of 2007; HR 4, Medicare Prescription Drug Price Negotiation Act of 2007; S 3, Medicare Prescription Drug Price Negotiation Act of 2007; S 1102, Part D Equity for Low-Income Seniors Act of 2007; S 1103, Helping Fill the Medicare Rx Gap Act of 2007; S 1107, Home and Community Services Copayment Equity Act of 2007; S 1108, Medicare Part D Outreach and Enrollment Enhancement Act of 2007; HR 2945, Medicare Advantage Truth in Advertising Act of 2007; S 799, Community Choice Act of 2007; S 1544, Medicare Quality Enhancement Act of 2007; S 1507, Access to Medicare Data Act of 2007; S 1827, Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007; HR 3025, Medicare Prescription Drug Savings for Our Seniors (Medicare Prescription Drug SOS) Act of 2007; HR 3061, Medicare Part D Drug Class Protection Act of 2007; HR 3162, Children's Health and Medicare Protection Act of 2007; HR 976, Children's Health Insurance Program Reauthorization Act of 2007; S 1893, Children's Health Insurance Program Reauthorization Act of 2007; S 1954, Pharmacy Access Improvement (PhAIm) Act of 2007; HR 3963, Children's Health Insurance Program Reauthorization Act of 2007; S 2219, Medicare Prescription Drug Savings and Choice Act of 2007; HR 3932, Medicare Prescription Drug Savings and Choice Act of 2007; S 2408, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; HR 4296, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; S 1200, Indian Health Care Improvement Act Amendments of 2008; HR 5480, Medicare Funding Warning Response Act of 2008; S 2662, Medicare Funding Warning Response Act of 2008; HR 5268, To provide for a temporary increase of the Federal medical assistance percentage under the Medicaid Program; HR 6388, Government Accountability Office Improvement Act of 2008; HR 5998, Fair and Justifiable Credit Card Interest Rate Act of 2008; S 2819, Economic Recovery in Health Care Act of 2008; HR 6359, Medicare Beneficiary Protection Act of 2008; HR 6365, Medicare Special Needs Plans Extension and Amendments Act of 2008; HR 5613, Protecting the Medicaid Safety Net Act of 2008; S 2620, To provide for a temporary increase of the Federal medical assistance percentage under the Medicaid program; S 3101, Medicare Improvements for Patients and Providers Act of 2008; HR 5683, Government Accountability Office Act of 2008; HR 7110, Job Creation and Unemployment Relief Act of 2008; S 3560, QI Program Supplemental Funding Act of 2008; HR 7077, QI Program Supplemental Funding Act of 2008; SJRes 44, blocking implementation of SCHIP; HRes 1368, Resolved, That section 803 of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 shall not apply during the remainder of the 110th Congress; S 3604, Emergency Supplemental.

Client expense: Not reported · Firm income: $100,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office

H.R. 6331/ S. 3101 - Medicare Improvements for Patients and Providers Act of 2008 (P.L. 110-275) Sections on Medicaid AMP, Medicare Part D prompt payment, DME Competitive Bidding, Prescription Drug pricing, and e-prescribing H.Res. 1368 - Relating to the House procedures contained in section 803 of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 H.R. 4296/ S. 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007 H.R. 3700/ S. 1951 - Fair Medicaid Drug Payment Act of 2007 H.R. 3140 - Saving Our Community Pharmacies Act of 2007 H.R. 6252/S. 3144 - Medicare DMEPOS Competitive Acquisition Reform Act of 2008 H.R. 5780 - Medicare Clinical Practitioner Services Coverage Act of 2008 H.R. 5613 - Medicaid Safety Net Act of 2008 H.R. 2408/ S. 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007 H.R. 971 - Community Pharmacy Fairness Act S. 1827 - Pharmacist Access and Recognition in Medicare (PhARM) of 2007 S. 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007 H.R. 3025 - Medicare Prescription Drug Savings for Our Seniors Act of 2007 S. 1954 Pharmacy Access Improvement Act (PhAIM) of 2007 (Docket Number: CMS-4121-F) CMS Final Rule on Prohibiting Midyear Changes to Medicare Advantage Plans (Docket Number: CMS 4131-P) CMS Proposed Changes to Medicare Program; Revisions to the Medicare Advantage and Prescription Drug Benefits Programs (Docket Number: CMS 4131F) CMS Final Rule on Medicare Program; Medicare Advantage and Prescription Drug Benefit Programs: Final Marketing Provisions (Docket Number: CMS-1403-P) CMS Amendment on Medicare Program; Revisions to Amendment of the E-Prescribing Exemption for Computer-Generated Facsimiles (Docket Number: CMS-1405-N) CMS Notice on Medicare Provider Feedback Group Town Hall Meeting (Docket Number: CMS-7011-N) CMS Notice on Medicare Program: Request for Cosponsors for E-prescribing Educational Conference (Public Law 110-28 and Public Law 110-90) Medicaid's Tamper-Resistance Prescription Pad Requirement (Public Law 109-171) Deficit Reduction Act of 2005 Section on Average Manufacturers Price (AMP)

Client expense: $196,642 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, White House Office

Issues related to pharmacy payments, the Medicare Part D and competitive bidding. H.R. 1474, Fair and Speedy Treatment (FAST) Act S. 1827, Pharmacist Access and Recognition in Medicare Act of 2007 S. 1954, Pharmacy Access Improvement PhAIm) Act of 2007 S. 1951, Fair Medicaid Drug Payment Act of 2007 HR 3700, Fair Medicaid Drug Payment Act of 2007 HR 3140, Saving Our Community Pharmacies Act of 2007 S 3101 and HR 6331 the Medicare Improvements for Patients Providers Act of 2008 HR 6252, Medicare DMEPOS Competitive Acquisition Reform Act of 2008 S. 3144, Medicare DMEPOS Competitive Acquisition Reform Act of 2008 S 3118, Preserving Access to Medicare Act of 2008

Client expense: $1,316,532 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

MMM (Legislative Issues): H.R. 4: Medicare Prescription Drug Price Negotiation Act (Dingell); H.R. 976: Childrens Health Insurance Program Reauthorization Act (Rangel) (continued) H.R. 1990: Medicare Cost Contract Extension and Refinement Act (Pomeroy); H.R. 2945: Medicare Advantage Truth in Advertising Act (Stark); H.R. 3025: Medicare Prescription Drug Savings for Our Seniors Act (Doggett); H.R. 3061: Medicare Part D Drug Class Protection Act (Doggett); H.R. 3162: Childrens Health and Medicare Protection Act (Dingell); H.R. 3932: Medicare Prescription Drug Savings and Choice Act (Berry); H.R. 3963: Childrens Health Insurance Program Reauthorization Act (Dingell); H.R. 4296: Medicare Electronic Medication and Safety Protection Act (Schwartz); H.R. 5268: Medicaid FMAP (Pallone); H.R. 5480: Medicare Funding Warning Response Act (Hoyer-Boehner); H.R. 5613: Protecting the Medicaid Safety Net Act (Dingell); H.R. 5683: GAO Act (provisions relating to access to Medicare part C/part D data) (Davis); H.R. 5998: Protecting Children's Health Coverage Act (Pallone); H.R. 6331: Medicare Improvements for Patients and Providers Act (provisions relating to Medicare Advantage, Medicare Part D, Medigap, Medicaid, health care disparities, and electronic prescribing) (Rangel-Dingell); H.R. 6388: GAO Improvement Act (provisions relating to access to Medicare part C/part D data) (Waxman); H.R. 6359: Medicare Beneficiary Protection Act (Biggert); H.R. 6365: Medicare Special Needs Plans Extension and Amendments Act (Kind); H.R. 7077: QI Program Supplemental Funding Act (Dingell) (provisions relating to cost sharing assistance for low-income Medicare beneficiaries); H.Res. 1368 (provisions relating to Medicare Funding Warning); S. 3: Medicare Prescription Drug Price Negotiation Act (Reid); S. 130: Medicare Cost Contract Extension and Refinement Act (Allard); S. 706: Medicare Advantage Stabilization Fund (Feingold); S. 799: Community Choice Act (Harkin); S. 1102: Part D Equity for Low-Income Seniors Act (Bingaman); S. 1103: Helping Fill the Medicare Rx Gap Act (Bingaman); S. 1107: Home and Community Services Copayment Equity Act (Smith); S. 1108: Medicare Part D Outreach and Enrollment Enhancement Act (Smith); S. 1200: Indian Health Care Improvement Act (includes Medicaid/MA provisions); S. 1507: Access to Medicare Data Act (Grassley); S. 1544: Medicare Quality Enhancement Act (Gregg); S. 1827: Pharmacist Access and Recognition in Medicare Act (Cochran); S. 1893: Childrens Health Insurance Program Reauthorization Act (Baucus); S. 1954: Pharmacy Access Improvement Act (Baucus); S. 2219: Medicare Prescription Drug Savings and Choice Act (Durbin); S. 2408: Medicare Electronic Medication and Safety Protection Act (Kerry); S. 2620: Medicaid FMAP (Rockefeller); S. 2662: Medicare Funding Warning Response Act (Baucus-Gregg); S. 2795: Small Business Health Options Program Act (Durbin-Snowe); S. 2819: Economic Recovery in Health Care Act (provisions relating to Medicaid funding) (Rockefeller); S. 3101: Medicare Improvements for Patients and Providers Act (provisions relating to Medicare Advantage, Medicare Part D, Medigap, Medicaid, health care disparities, electronic prescribing) (Baucus); S. 3560: QI Program Supplemental Funding Act (Baucus) (provisions relating to cost sharing assistance for low-income Medicare beneficiaries); S. 3604: Emergency Supplemental Appropriations Act (provisions relating to Medicaid FMAP); and S.J.Res. 44 (provisions relating to blocking implementation of SCHIP requirements). MMM (Regulatory Issues) Ongoing implementation issues for the Medicare Advantage (MA) and Medicare Part D prescription drug programs, including risk adjustment methodology and data issues, (including audit and encounter data issues) bidding and payment issues (including MA coding intensity, Part D reinsurance, low income subsidies, application process, and audits), application process, and audits, benefit design rules, SSA and CMS premium withhold processing issues, systems issues affecting enrollment and disenrollment processing, enrollment rules, marketing materials review and approval, marketing activities, including conduct and compensation of brokers and agents and plan sponsor marketing staff, measurement and oversight of plan performance including Special Needs Plans (SNPs); grievance and appeals processes, compliance/fraud and abuse training, and Medicare/Medicaid integration issues for Special Needs Plans (SNPs); Federal premption of State authority over MA and Part D plans, Part D prescription drug event data reporting, Part D formulary rules, Part D pharmacy access standards, and other operational issues; Medicare creditable drug coverage reporting requirements; implementation issues for the Medicare Retiree Drug Subsidy program; functionality of the Medicare Personal Plan Finder and Drug Plan Finder; National Medicare Education program; ongoing implementation issues for the Medicare cost plan program including enrollment, marketing materials review and approval, systems issues affecting enrollment and disenrollment processing, payment and other operational issues; Medicare demonstration program on performance-based payments for physician groups; physician quality reporting inititiative; issues relating to Medicare coverage policy and national coverage decisions; Medicare clinical trials; Medicaid managed care regulations and policies, including the Medicaid managed care actuarial soundness standard, quality oversight, grievance and appeals processes, beneficiary information requirements, treatment of Medicaid health plan member hospital days in the upper payment limit calculation; policies affecting State Medicaid funding, including intergovernmental transfers (IGTs); coordination of benefits with state Medicaid programs; Medicaid prescription drug cost/rebate issues affecting Medicaid health plans; health plan-related State Childrens Health Insurance Program (SCHIP) issues, including eligibility and outreach issues; implementation of Medicaid changes made in Deficit Reduction Act of 2005, including documentation of citizenship requirements, state benefit flexibility options, and Medicaid managed care organization provider tax issues; standards for electronic prescribing; and health information technology standards and policies.

Client expense: $1,630,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Office of Personnel Management (OPM), SENATE, Social Security Administration (SSA), Treasury, Dept of

Issues pertaining to implementation of the Medicare Prescription drug benefit HR.1474, Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007 S.1827, Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007 S.1954, Pharmacy Access Improvement (PhAIm) Act of 2007 S.1951, Fair Medicaid Drug Payment Act of 2007 HR.3700, Fair Medicaid Drug Payment Act of 2007 HR.3140, Saving Our Community Pharmacies Act of 2007 S.3101, Medicare Improvements for Patients and Providers Act of 2008 S.3118, Preserving Access to Medicare Act of 2008 HR.6331, Medicare Improvements for Patients and Providers Act of 2008 S.2408, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007 HR.4296, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

See addendum. H.R.970, the Dextromethorphan Distribution Act, as related to the abuse of dextromethorphan. H.R.971, the Community Pharmacy Fairness Act, as related to provider negotiations in the Medicare program. H.R.1108, Family Smoking Prevention and Tobacco Control Act, as related to the regulation of the sale of tobacco products. H.R.1424, the Emergency Economic Stabilization Act of 2008, as related to fiscal sustainablity for healthcare services. H.R.1474, the Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act, as related to provider reimbursement in the Medicare program. H.R.3700, the Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement in the Medicaid program. H.R.4008, Credit and Debit Card Receipt Clarification Act of 2007, as related to fair credit card practices. H.R.5491, Emilys Act, as related to the certification of pharmacy technicians. H.R.5546, Credit Card Fair Fee Act of 2008, as related to fair credit card practices. H.R.5613, Protecting the Medicaid Safety Net Act of 2008, as related to provider participation in the Medicaid program. H.R.5658, Duncan Hunter National Defense Authorization Act for Fiscal Year 2009, as related to provider participation in the TRICARE program. H.R.5839, Safeguarding America's Pharmaceuticals Act of 2008, as related to drug safety and electronic tracking of pharmaceuticals. H.R.6353/S.980, Ryan Haight Online Pharmacy Consumer Protection Act of 2008, as related to online pharmacies. H.R.6357, PRO(TECH)T Act of 2008, as related to pharmacy involvement in health information technology. H.R. 6491/S.3434, the Organized Retail Crime Act of 2008, as related to the prosecution of organized theft. H.R. 6713, the E-Fencing Enforcement Act of 2008, as related to the prosecution of organized theft. H.R. 6831/S.3666, the Copper Theft Prevention Act of 2008 as related to theft and interstate fencing of stolen copper. H.R. 6898, the Health-e Information Technology Act of 2008 as related to pharmacy involvement in health information technology H.R. 7110, the Job Creation and Unemployment Relief Act of 2008, as related to increased funding for state Medicaid programs. S.484, the Enhancing Drug Safety and Innovation Act, all provisions related to the safety of prescription medicines. S. 1276, the Methamphetamine Production Prevention Act as related to recordkeeping requirements for pharmacies. S.1693, Wired for Health Care Quality Act, as related to health information technology. S.1827, Pharmacists Access and Recognition in Medicare (PhARM) Act, as related to provider participation in the Medicare program. S.1915, Electronic Prescribing Drug Act, as related to the regulation of electronic prescribing of pharmaceuticals. S.1951, the Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement in the Medicaid program. S.1954, Pharmacy Access Improvement (PhAIm) Act, as related to access standards to pharmacies. S.2013/H.R.390, Patient and Pharmacy Protection Act, as related to prescription requirements in the Medicaid program. S.2071, Combat Methamphetamine Enhancement Act, as related to the distribution of legal substances used in the production of methamphetamine. S.2274, Dextromethorphan Abuse Reduction Act, as related to the abuse of dextromethorphan. S.2408/H.R.4296, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007, as related to electronic health care in the Medicare program. S.2978, Credit and Debit Card Receipt Clarification Act of 2008, as related to fair credit card practices S.3001, National Defense Authorization Act for Fiscal Year 2009, as related to provider participation in the TRICARE program. S.3086, Credit Card Fair Fee Act of 2008, as related to fair credit card practices. S.3101/H.R.6331, Medicare Improvements for Patients and Providers Act of 2008, as related to pharmacy reimbursement in the Medicaid and Medicare programs and electronic health care.

Client expense: $300,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), President of the U.S., SENATE

Medicare Part D: prompt pay/EFT for pharmacies (HR 1474/S 1827/S 1954/HR 6331), Changes to the part D benefit (HR 3162/S 2499/HR 6331), Electronic prescribing and eRx for controlled substances (HR 4296/S 2408/HR 6331), access to Medicare Data (HR 6388/S 1507/HR 6331), various regulatory issues related to Part D benefit. Medicare Part B: Changes to the competitive acquisition program for biologics (HR 3162) and prompt pay exclusion for distribution (HR 2770); AMP changes (HR 6331)

Client expense: $240,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE

MMM (Legislative Issues): H.R. 4: Medicare Prescription Drug Price Negotiation Act (Dingell); H.R. 976: Childrens Health Insurance Program Reauthorization Act (Rangel); H.R. 1535: Children's Health First Act (Dingell); H.R. 1663: Medicare Mental Health Modernization Act (Stark) (continued) H.R. 1990: Medicare Cost Contract Extension and Refinement Act (Pomeroy); H.R. 2147: Healthy Kids Act (Emanuel); H.R. 2945: Medicare Advantage Truth in Advertising Act (Stark); H.R. 2642: Supplemental Appropriations Act (provisions relating to moratoria on Medicaid regulations); H.R. 2842: Childrens Health Protection Act (Schwartz); H.R. 3025: Medicare Prescription Drug Savings for Our Seniors Act (Doggett); H.R. 3061: Medicare Part D Drug Class Protection Act (Doggett); H.R. 3162: Childrens Health and Medicare Protection Act (Dingell); H.R. 3195: ADA Amendments Act (Hoyer); H.R. 3932: Medicare Prescription Drug Savings and Choice Act (Berry); H.R. 3963: Childrens Health Insurance Program Reauthorization Act (Dingell); H.R. 4296: Medicare Electronic Medication and Safety Protection Act (Schwartz); H.R. 5268: Medicaid FMAP (Pallone); H.R. 5480: Medicare Funding Warning Response Act (Hoyer-Boehner); H.R. 5550: Coverage for Young Adult Dependents of Federal Employees (Davis); H.R. 5613: Protecting the Medicaid Safety Net Act (Dingell); H.R. 5683: GAO Act (provisions relating to access to Medicare part C/part D data) (Davis); H.R. 5781: Federal Employees Paid Parental Leave Act (Maloney); H.R. 5840: Insurance Information Act (Kanjorski); H.R. 5918: Small Business Health Options Program Act (Barrow); H.R. 5923: Patients Health Care Reform Act (Shadegg); H.R. 5955: Making Health Care More Affordable Act (Walberg); H.R. 5998: Protecting Children's Health Coverage Act (Pallone); H.R. 6071: Health Care Consumer Protection Act (provisions relating to reinstatement of health insurance following nonpayment of premiums) (Forbes); H.R. 6081: Heroes Earning Assistance and Relief Tax Act (mental health parity and FSA provisions); H.R. 6142: Lawsuits Against Employer-Sponsored Disability Benefit Plans (Andrews); H.R. 6210: Small Business Health Options Program Act (Kind-English); H.R. 6331: Medicare Improvements for Patients and Providers Act (provisions relating to Medicare Advantage, Medicare Part D, Medigap, Medicaid, health care disparities, and electronic prescribing) (Rangel-Dingell); H.R. 6388: GAO Improvement Act (provisions relating to access to Medicare part C/part D data) (Waxman); H.R. 6359: Medicare Beneficiary Protection Act (Biggert); H.R. 6365: Medicare Special Needs Plans Extension and Amendments Act (Kind); S. 3: Medicare Prescription Drug Price Negotiation Act (Reid); S. 130: Medicare Cost Contract Extension and Refinement Act (Allard); S. 401: Keep Children Covered Act (Rockefeller); S. 706: Medicare Advantage Stabilization Fund (Feingold); S. 799: Community Choice Act (Harkin); S. 895: Children's Health First Act (Clinton); S. 1102: Part D Equity for Low-Income Seniors Act (Bingaman); S. 1103: Helping Fill the Medicare Rx Gap Act (Bingaman); S. 1107: Home and Community Services Copayment Equity Act (Smith); S. 1108: Medicare Part D Outreach and Enrollment Enhancement Act (Smith); S. 1200: Indian Health Care Improvement Act (includes Medicaid/MA provisions); S. 1224: Children's Health Insurance Program Reauthorization Act (Rockefeller); S. 1507: Access to Medicare Data Act (Grassley); S. 1544: Medicare Quality Enhancement Act (Gregg); S. 1827: Pharmacist Access and Recognition in Medicare Act (Cochran); S. 1893: Childrens Health Insurance Program Reauthorization Act (Baucus); S. 1954: Pharmacy Access Improvement Act (Baucus); S. 2219: Medicare Prescription Drug Savings and Choice Act (Durbin); S. 2408: Medicare Electronic Medication and Safety Protection Act (Kerry); S. 2620: Medicaid FMAP (Rockefeller); S. 2662: Medicare Funding Warning Response Act (Baucus-Gregg); S. 2795: Small Business Health Options Program Act (Durbin-Snowe); S. 2819: Economic Recovery in Health Care Act (provisions relating to Medicaid funding) (Rockefeller); S. 2948: Small Business Empowerment Act (Brown); S. 2818: Small Business Health Plans Act (Enzi); S. 2999: Access to Cancer Clinical Trials Act (Brown); S. 3068: Equity in Prescription Insurance and Contraceptive Coverage Act (Snowe); S. 3101: Medicare Improvements for Patients and Providers Act (provisions relating to Medicare Advantage, Medicare Part D, Medigap, Medicaid, health care disparities, electronic prescribing) (Baucus); S. 3115: Childrens Health Protection Act (Lautenberg); S. 3118: Preserving Access to Medicare Act (provisions relating to Medicare Advantage, Medicare Part D, Medicaid, and electronic prescribing)(Grassley). MMM (Regulatory Issues) Ongoing implementation issues for the Medicare Advantage (MA) and Medicare Part D prescription drug programs, including risk adjustment methodology and data issues, (including encounter data issues) bidding and payment issues (including MA coding intensity, Part D reinsurance, low income subsidies, application process, and audits), application process, and audits, benefit design rules, SSA and CMS premium withhold processing issues, systems issues affecting enrollment and disenrollment processing, enrollment rules, marketing materials review and approval, marketing activities, including conduct of brokers and agents and plan sponsor marketing staff and issues raised by CMS about Private Fee-for-Service (PFFS) plan marketing, measurement and oversight of plan performance including Special Needs Plans (SNPs); grievance and appeals processes, compliance/fraud and abuse training, and Medicare/Medicaid integration issues for Special Needs Plans (SNPs); Federal premption of State authorization over MA and Part D plans, Part D prescription drug event data reporting, Part D formulary rules, Part D pharmacy access standards, and other operational issues; Medicare creditable drug coverage reporting requirements; implementation issues for the Medicare Retiree Drug Subsidy program; functionality of the Medicare Personal Plan Finder and Drug Plan Finder; National Medicare Education program; ongoing implementation issues for the Medicare cost plan program including enrollment, marketing materials review and approval, systems issues affecting enrollment and disenrollment processing, payment and other operational issues; Medicare demonstration program on performance-based payments for physician groups; physician quality reporting inititiative; issues relating to Medicare coverage policy and national coverage decisions; Medicare clinical trials; Medicaid managed care regulations and policies, including the Medicaid managed care actuarial soundness standard, quality oversight, grievance and appeals processes, beneficiary information requirements, treatment of Medicaid health plan member hospital days in the upper payment limit calculation; policies affecting State Medicaid funding, including intergovernmental transfers (IGTs) and federal matching funds for graduate medical education; coordination of benefits with state Medicaid programs; Medicaid prescription drug cost/rebate issues affecting Medicaid health plans; health plan-related State Childrens Health Insurance Program (SCHIP) issues, including eligibility and outreach issues; implementation of Medicaid changes made in Deficit Reduction Act of 2005, including documentation of citizenship requirements, state benefit flexibility options, and Medicaid managed care organization provider tax issues; standards for electronic prescribing; and health information technology standards and policies.

Client expense: $1,850,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Office of Personnel Management (OPM), SENATE, Social Security Administration (SSA), Treasury, Dept of

H.R. 1474, Fair and Speedy Treatment (FAST) Act; S. 1827, Pharmacist Access and Recognition in Medicare Act of 2007; S. 3162, Children's Health and Medicare Protection Act of 2007; S. 2499, Medicare, Medicaid and SCHIP Extension Act of 2007; HR 976, Children's Health Insurance Program Reauthorization Act of 2007; S. 1954, Pharmacy Access Improvement PhAIm) Act of 2007; S. 1951, Fair Medicaid Drug Payment Act of 2007 HR 3700, Fair Medicaid Drug Payment Act of 2007 HR 3140, Saving Our Community Pharmacies Act of 2007 HR 3101 and HR 6331 the Medicare Improvements for Patients Providers Act of 2008 HR 6252 Medicare DMEPOS Competitive Acquisition Reform Act of 2008 S. 3144 Medicare DMEPOS Competitive Acquisition Reform Act of 2008

Client expense: $1,010,101 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

H.R. 3700/ S. 1951 Fair Medicaid Drug Payment Act of 2007 H.R. 3140 Saving Our Community Pharmacies Act of 2007 S. 3101/ H.R. 6331 Medicare Patients and Providers Act of 2008 sections on AMP, Prompt Payment of Part D Claims, DME Competitive Bidding, and Prescription Drug Pricing Updates H.R. 6252/ S. 3144 Medicare DMEPOS Competitive Acquisition Reform Act of 2008 H.R. 5780 Medicare Clinical Practitioner Services Coverage Act of 2008 H.R. 5613 Medicaid Safety Net Act of 2008 H.R. 2408/ S. 2408 Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007 H.R. 971 Community Pharmacy Fairness Act S. 1827 Pharmacist Access and Recognition in Medicare (PhARM) of 2007 S. 1474 Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007 H.R. 3025 Medicare Prescription Drug Savings for Our Seniors Act of 2007 S. 1954 Pharmacy Access Improvement Act (PhAIM) of 2007 (Public Law 110-28 and Public Law 110-90) Medicaid's Tamper-Resistance Prescription Pad Requirement (Public Law 109-171) Deficit Reduction Act of 2005 section on Average Manufacturers Price (AMP) (Docket Number: CMS -4119-F) Medicare Program; Medicare Part D Claims Data (Docket Number: CMS 4131P) Medicare Program; Revisions to the Medicare Advantage and Prescription Drug Benefit Programs; Proposed Rule (Docket Number: CMS-2238-IFC) Medicaid Program; Multiple Source Drug Definition DRAFT and FINAL CMS 2009 Medicare Part D Call Letter (Docket Number: CMS0016F and CMS0018F) Medicare Program; Standards for E-Prescribing Under Medicare Part D and Identification of Backward Compatible Version of Adopted Standard for EPrescribing and the Medicare Prescriptions Drug Program (Version 8.1); Final Rule (Docket Numeber: CMS-2008-0009-0002)Medicare Program; Option for Prescription Drug Plans to Lower their Premiums for Low-Income Subsidy Beneficiaries

Client expense: $183,962 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE

Issues pertaining to implementation of the Medicare Prescription drug benefit HR.1474, Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007 S.1827, Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007 HR.3162, Children's Health and Medicare Protection Act of 2007 S.1954, Pharmacy Access Improvement (PhAIm) Act of 2007 S.1951, Fair Medicaid Drug Payment Act of 2007 HR.3700, Fair Medicaid Drug Payment Act of 2007 HR.3140, Saving Our Community Pharmacies Act of 2007 S.3101, Medicare Improvements for Patients and Providers Act of 2008 S.3118, Preserving Access to Medicare Act of 2008 HR.6331, Medicare Improvements for Patients and Providers Act of 2008

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare Part D: prompt pay/EFT for pharmacies (HR 1474/S 1827/ S 1954/HR 6331), changes to the Part D benefit (HR 3162/S 2499/HR 6331), electronic prescribing (H.R. 4296/S 2408/ HR 6331), Access to Medicare Data (H.R. 6388/S 1507), various regulatory issues related to implementing the Medicare Part D benefit. Medicare Part B: Changes to the competitive acquisition program (HR 3162); prompt pay exculsion from Part B (HR 2770) Items related to the definition of Medicaid Average Manufacture Price (AMP) as espoused by the 2005 Deficit Reduction Act. (HR 3700/HR 6331)

Client expense: $210,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE, White House Office

See addendum. H.R.970, the Dextromethorphan Distribution Act, as related to the abuse of dextromethorphan. H.R.971, the Community Pharmacy Fairness Act, as related to provider negotiations in the Medicare program. H.R.1038/S.623, Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. H.R.1108, Family Smoking Prevention and Tobacco Control Act, as related to the regulation of the sale of tobacco products. H.R.1474, the Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act, as related to provider reimbursement in the Medicare program. H.R.3140, Saving Our Community Pharmacies Act, as related to Medicaid provider reimbursement. H.R.3193, Access to Community Pharmacy Preservation Act, as related to Medicaid provider reimbursement. H.R.3700, the Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement in the Medicaid program. H.R.4008, Credit and Debit Card Receipt Clarification Act of 2007, as related to fair credit card practices. H.R.5491, Emilys Act, as related to the certification of pharmacy technicians. H.R.5546, Credit Card Fair Fee Act of 2008, as related to fair credit card practices. H.R.5613, Protecting the Medicaid Safety Net Act of 2008, as related to provider participation in the Medicaid program. H.R.5629, Pathway for Biosimilars Act, as related to the availability of generic pharmaceuticals. H.R.5658, Duncan Hunter National Defense Authorization Act for Fiscal Year 2009, as related to provider participation in the TRICARE program. H.R.5839, Safeguarding America's Pharmaceuticals Act of 2008, as related to drug safety and electronic tracking of pharmaceuticals. H.R.6252, Medicare DMEPOS Competitive Acquisition Reform Act of 2008, as related to provider participation in the Medicare competitive bidding program. H.R.6331, the Medicare Improvements for Patients and Providers Act of 2008, as related to pharmacy reimbursement, electronic health care, and Medicare programs. H.R.6353, Ryan Haight Online Pharmacy Consumer Protection Act of 2008, as related to online pharmacies. H.R.6357, PRO(TECH)T Act of 2008, as related to health information technology. S.484, the Enhancing Drug Safety and Innovation Act, all provisions related to the safety of prescription medicines. S.980, Ryan Haight Online Pharmacy Consumer Protection Act of 2008, as related to online pharmacies. S.1693, Wired for Health Care Quality Act, as related to health information technology. S.1695, the Biologics Price Competition and Innovation Act, as related to the approval of generic biopharmaceuticals. S.1827, Pharmacists Access and Recognition in Medicare (PhARM) Act, as related to provider participation in the Medicare program. S.1915, Electronic Prescribing Drug Act, as related to the regulation of electronic prescribing of pharmaceuticals. S.1951, the Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement in the Medicaid program. S.1954, Pharmacy Access Improvement (PhAIm) Act, as related to access standards to pharmacies. S.2013/H.R.390, Patient and Pharmacy Protection Act, as related to prescription requirements in the Medicaid program. S.2071, Combat Methamphetamine Enhancement Act, as related to the distributio of legal substances used in the production of methamphetamine. S.2274, Dextromethorphan Abuse Reduction Act, as related to the abuse of dextromethorphan. S.2408/H.R.4296, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007, as related to electronic health care in the Medicare program. S.2978, Credit and Debit Card Receipt Clarification Act of 2008, as related to fair credit card practices S.3001, National Defense Authorization Act for Fiscal Year 2009, as related to provider participation in the TRICARE program. S.3086, Credit Card Fair Fee Act of 2008, as related to fair credit card practices. S.3101, Medicare Improvements for Patients and Providers Act of 2008, as related to pharmacy reimbursement and electronic health care.

Client expense: $420,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), President of the U.S., SENATE

H.R. 1474, Fair and Speedy Treatment (FAST) Act; S. 1954, Baucus/Grassley bill; S. 1827, Pharmacist Access and Recognition in Medicare Act of 2007; S. 3162, Children's Health and Medicare Protection Act of 2007; S. 2499, Medicare, Medicaid and SCHIP Extension Act of 2007; HR 976, Children's Health Insurance Program Reauthorization Act of 2007; S. 1954, Pharmacy Access Improvement PhAIm) Act of 2007; S. 1951, Fair Medicaid Drug Payment Act of 2007

Client expense: $928,643 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

H.R. 1474, Fair and Speedy Treatment (FAST) Act; S. 1954, Baucus/Grassley bill; S. 1827, Pharmacist Access and Recognition in Medicare Act of 2007; S. 3162, Children's Health and Medicare Protection Act of 2007; S. 2499, Medicare, Medicaid and SCHIP Extension Act of 2007; HR 976, Children's Health Insurance Program Reauthorization Act of 2007; S. 1954, Pharmacy Access Improvement PhAIm) Act of 2007; S. 1951, Fair Medicaid Drug Payment Act of 2007

Client expense: $928,643 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

HR 971 Community Pharmacy Fairness Act of 2007 HR 2970 Pharmacy Benefit Manager Transparency Act of 2007 HR 3140 Saving Our Community Pharmacies Act of 2007 HR 3090 Patient and Pharmacy Protection Act of 2007; E-prescribing HR 3193 Access to Community Pharmacy Preservation Act of 2007 S 885 Community Pharmacy Fairness Act of 2007 S 980 Online Pharmacy Consumer Protection Act of 2007 S 1827 Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007 S 1954 Pharmacy Access Improvement (PhAIm) Act of 2007 S 2013 Patient and Pharmacy Protection Act of 2007 S 2085 Patient and Pharmacy Protection Act of 2007 S 2161 Community Pharmacy Fairness Act of 2007 Internet Pharmacies Off-Label Use of Prescription Drugs.

Client expense: Not reported · Firm income: $75,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues pertaining to implementation of the Medicare Prescription drug benefit HR.1474, Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007 S.1827, Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007 HR.3162, Children's Health and Medicare Protection Act of 2007 S.2499, Medicare, Medicaid, and SCHIP Extension Act of 2007 HR.976, Children's Health Insurance Program Reauthorization Act of 2007 S.1954, Pharmacy Access Improvement (PhAIm) Act of 2007 S.1951, Fair Medicaid Drug Payment Act of 2007 HR.3700, Fair Medicaid Drug Payment Act of 2007 HR.3140, Saving Our Community Pharmacies Act of 2007

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1474 Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007 H.R. 971 Community Pharmacy Fairness Act of 2007 H.R. 3700 Fair Medicaid Drug Payment Act of 2007 Public Law 110-28 and Public Law 110-90 Medicaid: Implementation of the Tamper-Resistant Prescription Pad Requirement H.R. 3140 Saving Our Community Pharmacies Act of 2007 S. 1954 Pharmacy Improvement Act (PhAIM) of 2007 S. 1827 Pharmacist Access and Recognition in Medicare (PhARM) of 2007 S. 1951 Fair Medicaid Drug Payment Act of 2007 S. 1474 Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims S. 2161 Community Pharmacy Fairness Act Docket No. CMS-4133-P Medicare Program: Option for Prescription Drug Plans to Lower Their Premiums for Low-Income Subsidy Beneficiaries S. 2464 Medicare Improvement Act of 2007 H.R. 4704 Medicare Improvement Act of 2007 H.R. 4992 Medicare Improvement Act of 2007 CMS 2009 Draft and Final 2009 Call Letter to Medicare Part D Plans Docket No. CMS-0016-P Medicare Program: Proposed Standards for e-Prescribing under Medicare Part D Docket No. CMS-2238-ICF Medicaid Program; Multiple Source Drug Definition

Client expense: $164,946 · Firm income: Not reported

Government targets: Administration on Aging, Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE

MMM (Legislative Issues): H.R. 4: Medicare Prescription Drug Price Negotiation Act (Dingell); H.R. 976: Childrens Health Insurance Program Reauthorization Act (Rangel); H.R. 1535: Children's Health First Act (Dingell); H.R. 1663: Medicare Mental Health Modernization Act (Stark) (continued) H.R. 1990: Medicare Cost Contract Extension and Refinement Act (Pomeroy); H.R. 2147: Healthy Kids Act (Emanuel); H.R. 2945: Medicare Advantage Truth in Advertising Act (Stark); H.R. 3025: Medicare Prescription Drug Savings for Our Seniors Act (Doggett); H.R. 3061: Medicare Part D Drug Class Protection Act (Doggett); H.R. 3162: Childrens Health and Medicare Protection Act (Dingell); H.R. 3932: Medicare Prescription Drug Savings and Choice Act (Berry); H.R. 3963: Childrens Health Insurance Program Reauthorization Act (Dingell); H.R. 4296: Medicare Electronic Medication and Safety Protection Act (Schwartz); H.R. 5268: Medicaid FMAP (Pallone); H.R. 5480: Medicare Funding Warning Response Act (Hoyer-Boehner); H.R. 5613: Protecting the Medicaid Safety Net Act (Dingell); S. 3: Medicare Prescription Drug Price Negotiation Act (Reid); S. 130: Medicare Cost Contract Extension and Refinement Act (Allard); S. 401: Keep Children Covered Act (Rockefeller); S. 706: Medicare Advantage Stabilization Fund (Feingold); S. 799: Community Choice Act (Harkin); S. 895: Children's Health First Act (Clinton); S. 1102: Part D Equity for Low-Income Seniors Act (Bingaman); S. 1103: Helping Fill the Medicare Rx Gap Act (Bingaman); S. 1107: Home and Community Services Copayment Equity Act (Smith); S. 1108: Medicare Part D Outreach and Enrollment Enhancement Act (Smith); S. 1200: Indian Health Care Improvement Act (includes Medicaid/MA provisions); S. 1224: Children's Health Insurance Program Reauthorization Act (Rockefeller); S. 1507: Access to Medicare Data Act (Grassley); S. 1544: Medicare Quality Enhancement Act (Gregg); S. 1827: Pharmacist Access and Recognition in Medicare Act (Cochran); S. 1893: Childrens Health Insurance Program Reauthorization Act (Baucus); S. 1954: Pharmacy Access Improvement Act (Baucus); S. 2219: Medicare Prescription Drug Savings and Choice Act (Durbin); S. 2408: Medicare Electronic Medication and Safety Protection Act (Kerry); S. 2620: Medicaid FMAP (Rockefeller); S. 2662: Medicare Funding Warning Response Act (Baucus-Gregg); S. Con. Res. 70: Budget Resolution; (Conrad); H. Con. Res. 312: Budget Resolution, section 201 (Spratt). MMM (Regulatory Issues) Ongoing implementation issues for the Medicare Advantage (MA) and Medicare Part D prescription drug programs, including risk adjustment methodology and data issues, bidding and payment issues (including MA coding intensity, Part D reinsurance, and low income subsidies), benefit design rules, SSA and CMS premium withhold processing issues, systems issues affecting enrollment and disenrollment processing, enrollment rules, marketing materials review and approval, marketing activities, including conduct of brokers and agents and plan sponsor marketing staff and issues raised by CMS about Private Fee-for-Service (PFFS) plan marketing, measurement and oversight of plan performance including Special Needs Plans (SNPs), grievance and appeals processes, Medicare/Medicaid integration issues for Special Needs Plans (SNPs), Part D prescription drug event data reporting, Part D formulary rules, Part D pharmacy access standards, and other operational issues; Medicare creditable drug coverage reporting requirements; implementation issues for the Medicare Retiree Drug Subsidy program; functionality of the Medicare Personal Plan Finder and Drug Plan Finder; National Medicare Education program; ongoing implementation issues for the Medicare cost plan program including enrollment, marketing materials review and approval, systems issues affecting enrollment and disenrollment processing, payment and other operational issues; Medicare demonstration program on performance-based payments for physician groups; physician quality reporting inititiative; issues relating to Medicare coverage policy and national coverage decisions; Medicare clinical trials; Medicaid managed care regulations and policies, including the Medicaid managed care actuarial soundness standard, quality oversight, grievance and appeals processes, beneficiary information requirements, treatment of Medicaid health plan member hospital days in the upper payment limit calculation; policies affecting State Medicaid funding, including intergovernmental transfers (IGTs) and federal matching funds for graduate medical education; coordination of benefits with state Medicaid programs; Medicaid prescription drug cost/rebate issues affecting Medicaid health plans; health plan-related State Childrens Health Insurance Program (SCHIP) issues, including eligibility and outreach issues; implementation of Medicaid changes made in Deficit Reduction Act of 2005, including documentation of citizenship requirements, state benefit flexibility options, and Medicaid managed care organization provider tax issues; standards for electronic prescribing; and health information technology standards and policies.

Client expense: $1,820,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Office of Personnel Management (OPM), SENATE, Social Security Administration (SSA), Treasury, Dept of

Medicare Part D: Prompt pay/EFT for pharmacies (HR 1474/S 1827); changes to the Part D benefit (HR 3162/S 2499); direct negotiation (HR 4/S 1); electronic prescribing (S2408/HR 4296; various regulatory issues related to implementing the Medicare Part D drug benefit. Medicare Part B: Changes to the competitive acquisition program (HR 3162); prompt pay exclusion from Part B (HR 2770) Issues related to the definition of Average Manufacture Price (AMP) as espoused by the Deficit Reduction Act of 2005.

Client expense: $180,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE, White House Office

HR 971 Community Pharmacy Fairness Act of 2007 HR 2970 Pharmacy Benefit Manager Transparency Act of 2007 HR 3140 Saving Our Community Pharmacies Act of 2007 HR 3090 Patient and Pharmacy Protection Act of 2007 HR 3193 Access to Community Pharmacy Preservation Act of 2007 S 885 Community Pharmacy Fairness Act of 2007 S 980 Online Pharmacy Consumer Protection Act of 2007 S 1827 Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007 S 1954 Pharmacy Access Improvement (PhAIm) Act of 2007 S 2013 Patient and Pharmacy Protection Act of 2007 S 2085 Patient and Pharmacy Protection Act of 2007 S 2161 Community Pharmacy Fairness Act of 2007 Internet Pharmacies Off-Label Use of Prescription Drugs.

Client expense: Not reported · Firm income: $75,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare Advantage - HR 3963, Children's Health Insurance Program Reauthorization Act of 2007; HConRes 312, CONCURRENT RESOLUTION ON THE BUDGET FOR FISCAL YEAR 2009; SConRes 70, Setting forth the congressional budget for the United States Government for fiscal year 2009. Medicare issues - S 706, Medicare Advantage Stabilization Fund; S 130, Medicare Cost Contract Extension/Refinement; HR 1990, Medicare Cost Contract Extension/Refinement; HR 4, Medicare Prescription Drug Price Negotiation; S 3, Medicare Prescription Drug Price Negotiation; S 1102, Medicare Part D Equity for Low Income Seniors; S 1103, Helping Fill the Medicare RX Gap; S 1107, Home-Community Services Copayment Equity; S 1108, Medicare Part D Outreach /Enrollment; HR 1663, Medicare Mental Health Modernization; HR 1535, Children's Health First Act; S 895, Children's Health First Act; S 1224, Children's Health Insurance Program Reauthorization; HR 2147, Healthy Kids Act; HR 2945, Medicare Advantage Truth in Advertising; S 799, Community Choice Act; S 401, Keep Children Covered Act; S 1544, Medicare Quality Enhancement Act; S 1507, Access to Medicare Data; S 1827, Pharmacist Access/Recognition in Medicare; HR 3025, Medicare Prescription Drug Savings for Seniors; HR 3061, Medicare Part D Drug Class Protection; HR 3162, Children's Health and Medicare Protection; HR 976, Children's Health Insurance Program Reauthorization; S 1893, Children's Health Insurance Program Reauthorization; S 1954, Pharmacy Access Improvement; S 2219, Medicare Prescription Drug Savings and Choice; HR 3932, Medicare Prescription Drug Savings and Choice; S 2408, Medicare Electronic Medication and Safety Protection; HR 4296, Medicare Electronic Medication and Safety Protection; S 1200, Indian Health Care Improvement Act; HR 5480, Medicare Funding Warning Response Act; S 2662, Medicare Funding Warning Response Act; HR 5268, Medicaid FMAP; S 2620, Medicaid FMAP

Client expense: Not reported · Firm income: $100,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office

See addendum. 1.S.242/H.R.380, the Pharmaceutical Market Access and Drug Safety Act of 2007, as related to provisions governing the importation of prescription drugs. 2.S.251, the Pharmaceutical Market Access Act of 2007, all provisions governing the importation of prescription drugs. 3.S. 484, the Enhancing Drug Safety and Innovation Act of 2007, all provisions related to the safety of prescription medicines. 4.S. 604, the Military Health Care Protection Act, as related to provider participation in the Department of Defense TRICARE program. 5.S. 980, Online Pharmacy Consumer Protection Act of 2007, as related to the regulation of online pharmacies. 6.S. 1200, Indian Health Care Improvement Act Amendments of 2007, all provisions related to reducing fraud and abuse in the Medicare program. 7.S. 1276/H.R.2747, the Methamphetamine Production Prevention Act of 2007, as related to the distribution of legal substances used in the production of methamphetamine. 8.S. 1693, the Wired for Health Care Quality Act of 2007, as related to improving health information technology. 9.S. 1695, the Biologics Price Competition and Innovation Act of 2007, as related to the approval of generic biopharmaceuticals. 10.S. 1827, Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007 as related to provider participation in the Medicare program. 11.S.1915, Electronic Prescription Drug Act of 2007, as related to the regulation of electronic prescribing of pharmaceuticals 12.S.1951/H.R.3700, Fair Medicaid Drug Payment Act of 2007, as related to Medicaid provider reimbursement. 13.S.1954, Pharmacy Access Improvement (PhAIm) Act of 2007, as related to access standards to pharmacies. 14.S.2013/H.R.3090, Patient and Pharmacy Protection Act of 2007, as related to prescription requirements in the Medicaid program. 15.S.2071, Combat Methamphetamine Enhancement Act of 2007, as related to the distribution of legal substances used in the production of methamphetamine. 16.S.2274, Dextromethorphan Abuse Reduction Act of 2007, as related to steps to prevent the abuse of dextromethorphan. 17.S.2408/H.R.4296, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007, as related to the regulation of electronic prescribing of pharmaceuticals. 18.H.R.976, Small Business Tax Relief Act of 2007, all provisions associated with work-related tax credits. 19.H.R. 970, the Dextromethorphan Distribution Act of 2007, as related to steps to prevent the abuse of dextromethorphan. 20.H.R. 971/S.855, the Community Pharmacy Fairness Act of 2007, as related to provider negotiations in the Medicare program. 21.H.R.1038/S.623, Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. 22.H.R. 1474, the Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007, as related to provider reimbursement in the Medicare program 23.H.R.1585/S.1548, National Defense Authorization Act for Fiscal Year 2008, as related to retail pharmacy participation in the Department of Defense TRICARE program. 24.H.R.1845, the Medicare Durable Medical Equipment Access Act of 2007, as related to provider inclusion in the Medicare Part B program. 25.H.R.1902, the Protecting Consumer Access to Generic Drugs Act of 2007, as related to the availability of generic pharmaceuticals. 26.H.R.2716, the Reducing Fraudulent and Imitation Drugs Act of 2007, as related to the safety of prescription drugs. 27.H.R. 2900, the Food and Drug Administration Amendments of 2007, all provisions related to prescription drug information and safety. 28.H.R.3109, the Dental Health Promotion Act of 2007, all provisions related to payment for health services. 29.H.R.3140, Saving Our Community Pharmacies Act of 2007, as related to Medicaid provider reimbursement. 30.H.R.3162, Children's Health and Medicare Protection Act of 2007, provisions related to health insurance in the Medicare program. 31.H.R.3193, Access to Community Pharmacy Preservation Act of 2007, as related to Medicaid provider reimbursement. 32.H.R.3580, Food and Drug Administration Amendments Act of 2007, all provisions related to prescription drug information and safety. 33.H.R.3610, Food and Drug Import Safety Act of 2007, provisions related to the safety of prescription drugs. 34.H.R.5268/S.2620, Temporary Increase of Medicaid FMAP, all provisions related to payments in the Medicaid program. 35.H.R.5480/S.2662, Medicare Funding Warning Response Act of 2008, all provisions related to provider access and payments in the Medicare program. 36.H.R.5491, Emilys Act, as related to the certification of pharmacy technicians. 37.H.R.5546, Credit Card Fair Fee Act of 2008, as related to fees associated with credit card purchase. 38.H.R.5613, Protecting the Medicaid Safety Net Act of 2008, all provisions related to provider participation in the Medicaid program. 39.H.R.5629, Pathway for Biosimilars Act, as related to the availability of generic pharmaceuticals. 40.H.Con.Res.312/S.Con.Res.70, Concurrent Resolution on the Budget for Fiscal Year 2009, all provisions related to healthcare providers and prescription drugs.

Client expense: $370,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Office of Natl Drug Control Policy (NDCP), Office of Personnel Management (OPM), President of the U.S., SENATE

Ambulatory Payment Classification (APC) Panel testimony and comments. APC Panel Nomination. Letters to CMS and CMS officials regarding compendia additions and deletions including American Hospital Formulary Service-Drug Information. Comments relating to electronic prescribing under Part D. HR 3025, Medicare Prescription Drug Savings for our Seniors Act of 2007 and S1827, Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007; provisions relating to medication therapy management. HR 3162, Children's Health and Medicare Protection Act (CHAMP Act), provisions on comparative effectiveness research. Recognition of pharmacists as health care providers and payment for clinical services. Recognition of AHFS as drug compendia for coverage of unlabeled uses. Funding for specialized pharmacy residency programs. Electronic prescribing.

Client expense: $200,276 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE

Medicare Part D Prescription Drug Benefit Tamper-Resistant Prescription Pad Requirement in Medicaid HR 3090 Patient and Pharmacist Protection Act of 2007 S 1951 Fair Medicaid Drug Payment Act of 2007 HR 3140 Patient Access to Medicaid Generic Prescription Drug Act of 2007 HR 1474 Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007 HR 971 Community Pharmacy Fairness Act HR 3700 Fair Medicaid Drug Payment Act of 2007 HR 3140 Saving Our Community Pharmacies Act of 2007 S 1954 Pharmacy Improvement Act (PhAIM) of 2007 S 1827 Pharmacist Access and Recognition in Medicare (PhARM) of 2007S 1951 Fair Medicaid Drug Payment Act of 2007 S 1474 Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007 S 2161 Community Pharmacy Fairness Act of 2007 S 2031 Patient and Pharmacist Protection Act of 2007S 1951 Fair Medicaid Drug Payment Act of 2007 S 2250 Ambulatory Surgical Center Medicare Payment Modernization Act of 2007 HR 1832 Ambulatory Surgical Center Medicare Payment Modernization Act of 2007 HR 3162 Children's Health and Medicare Protection Act of 2007 Docket No. CMS 2238-FC 72FR39142 - Submitted to the House Small Business Committee "Medicaid Drug Reimbursements: Are CMS Cuts Bad Medicine for Small Businesses and Beneficiaries?"

Client expense: $367,997 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, UNDETERMINED

Issues pertaining to the Medicare Prescription Drug Benefit H.R. 1474, S. 1954 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007 S. 1827 - Pharmacist Access and Recognition in Medicare Act of 2007 S. 3162 - Children's Health and Medicare Protection Act of 2007

Client expense: $457,385 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office

Issues pertaining to the Medicare Prescription Drug Benefit H.R. 1474, S. 1954 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007 S. 1827 - Pharmacist Access and Recognition in Medicare Act of 2007 S. 3162 - Children's Health and Medicare Protection Act of 2007

Client expense: $457,385 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office

Requirement to report National Drug Code Number to State Medicaid agencies (provision in Deficit Reduction Act.) H.R. 3090, provision delaying date requiring tamper resistant prescriptions. HR 3025, Medicare Prescription Drug Savings for our Seniors Act of 2007 and S1827, Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007; provisions relating to medication therapy management.

Client expense: $60,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE

Medicare Part D: Prompt pay/EFT for pharmacies (HR 1474, S 1827); changes to the Part D benefit (HR 3162/S. 2499)); direct negotiation (HR 4/ S 1); electronic prescribing (S2408/HR 4296); various regulatory issues related to implementing the Medicare Part D drug benefit Medicare Part B: Changes to the competitive acquisition program (HR 3162); prompt pay exclusion from ASP (HR 2770)

Client expense: $490,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office

Issues pertaining to implementation of the Medicare Prescription drug benefit HR.1474, Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007 S.1827, Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007 HR.3162, Children's Health and Medicare Protection Act of 2007

Client expense: Not reported · Firm income: $100,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues relating to the definition of Average Manufacture Price (AMP) as espoused by the Deficit Reduction Act Issues related to Medicare Part B and Part D: S. 870/HR 2567 to provide coverage of home infusion services and supplies under Medicare. Medicare Part D: Prompt pay/EFT for pharmacies (HR 1474, S 1827); changes to the Part D benefit (HR 3162/HR 976 (senate bill)); direct negotiation (HR 4/ S 1); electronic prescribing; various regulatory issues related to implementing the Medicare Part D drug benefit Medicare Part B: Changes to the competitive acquisition program (HR 3162); prompt pay exclusion from ASP (HR 2770)

Client expense: $490,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office

S.3, Medicare Prescription Drug Price Negotiation Act of 2007 HR.976, Children's Health Insurance Program Reauthorization Act of 2007 HR.4, Medicare Prescription Drug Price Negotiation Act of 2007 Issues pertaining to implementation of the Medicare Prescription drug benefit HR.1474, Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007 S.1827, Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007

Client expense: Not reported · Firm income: $100,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 3025 (Doggett) - a bill to amend SSA/Medicare to provide improvements to Medicare Prescription Drug Program S. 1340 (Lincoln) - a bill to amend SSA/Medicare to provide access to geriatric assessments/chronic care coordination, etc. S. 1827 (Cochran) - a bill to amend SSA/Medicare for changes to Part D benefit regarding payment, co-branding, and MTM services H.R. 3162 - (Dingell) - a bill to amend SSA to extend and improve children's health insurance program and beneficiary protections

Client expense: $114,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Issues relating to the definition of Average Manufacture Price (AMP) as espoused by the Deficit Reduction Act Issues related to Medicare Part B and Part D: S. 870/HR 2567 to provide coverage of home infusion services and supplies under Medicare. Medicare Part D: Prompt pay/EFT for pharmacies (HR 1474, S 1827); changes to the Part D benefit (HR 3162/HR 976 (senate bill)); direct negotiation (HR 4/ S 1); electronic prescribing; various regulatory issues related to implementing the Medicare Part D drug benefit Medicare Part B: Changes to the competitive acquisition program (HR 3162); prompt pay exclusion from ASP (HR 2770)

Client expense: $390,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office

S.1827; H.R. 1474; S. 1954; H.R. 2860; H.R. 3090; S. 2013; H.R. 2606; S. 1376; H.R. 2860; H.R. 3162; H.R. 2184

Client expense: $222,849 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

S. 1827; H.R. 1474; S. 1954; H.R. 2860; H.R. 3090; S. 2013; H.R. 2606; S. 1376; H.R. 2860; H.R. 3162; H.R. 2184

Client expense: $27,097 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

S. 1827; H.R. 1474; S. 1954; H.R. 2860; H.R. 3090; S. 2013; H.R. 2606; S. 1376; H.R. 2860; H.R. 3162; H.R. 2184

Client expense: Not reported · Firm income: $156,427

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office